1-5 of 5
Marc Berger
Close
Sort by
Journal Articles

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Joshua F Ransom, PhD, Aaron Galaznik, MDMBA, Emelly Rusli, Bruno Lempernesse, MS, Marc Berger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4895.
https://doi.org/10.1182/blood-2019-129086
Published: 2019
Journal Articles

Molecular Response, Efficacy and Safety Analysis of 168 Adult French Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck Emmanuel Nicolini, MD, PhD, Gabriel Etienne, MD, Dominique Bordessoule, Denis Caillot, MD, Coralie Belanger, Jean-Michel Cayuela, MD, Aude Charbonnier, Valerie Coiteux, MD, Agnès Guerci-Bresler, Viviane Dubruille, Thierry Lamy, MD, PhD, Francoise Huguet, Philippe Rousselot, MD, PhD, Michel Tulliez, Jean-Yves Cahn, Martine Gardembas-Pain, Laurence Legros, MD, Frederic Maloisel, Delphine Rea, MD, PhD, Hyacinthe Johnson-Ansah, MD, Pascal Lenain, Alain Delmer, MD, PhD, Marc Berger, MD, Tomasz Szczudlo, MD, Jim Wang, PhD, Mei Sheng Duh, MPH, ScD, Francois Guilhot, MD
Journal: Blood
Blood (2009) 114 (22): 3293.
https://doi.org/10.1182/blood.V114.22.3293.3293
Published: 2009
Journal Articles

Randomized Comparison of Imatinib Versus Imatinib Combination Therapies in Newly Diagnosed Chronic Myeloid Leukaemia (CML) Patients in Chronic Phase (CP): First Results of the Phase III (SPIRIT) Trial from the French CML Group (FI LMC)

Francois Guilhot, MD, François-Xavier Mahon, MD, PhD, Joelle Guilhot, MSci, Francoise Rigual-Huguet, MD, Frederic Maloisel, MD, Philippe Rousselot, MD, PhD, Martine Gardembas, MD, Selim Corm, MD, Agnes Guerci, MD, PhD, Anne Vekhoff, MD, Gabriel Etienne, MD, Laurence Legros, MD, Jean- Jacques Kiladjian, MD, PhD, Eric Jourdan, Michele Schoenwald, MD, Marc Berger, MD, Virginie Eclache, MD, Catherine Roche-Lestienne, PhD, Franck E Nicolini, MD, PhD, Claude Preudhomme, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 183.
https://doi.org/10.1182/blood.V112.11.183.183
Published: 2008
Journal Articles

Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Is Toxic to Blasts From Patients With Juvenile Myelomonocytic Leukemia and Chronic Myelomonocytic Leukemia

Arthur E. Frankel, Michael Lilly, Robert Kreitman, Donna Hogge, Miloslav Beran, Melvin H. Freedman, Peter D. Emanuel, Chris McLain, Philip Hall, Edward Tagge, Marc Berger, Connie Eaves
Journal: Blood
Blood (1998) 92 (11): 4279–4286.
https://doi.org/10.1182/blood.V92.11.4279
Published: 1998
Journal Articles

Malignant Progenitors From Patients With Acute Myelogenous Leukemia Are Sensitive to a Diphtheria Toxin–Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein

Donna E. Hogge, Cheryl L. Willman, Robert J. Kreitman, Marc Berger, Philip D. Hall, Kenneth J. Kopecky, Chris McLain, Edward P. Tagge, Connie J. Eaves, Arthur E. Frankel
Journal: Blood
Blood (1998) 92 (2): 589–595.
https://doi.org/10.1182/blood.V92.2.589
Published: 1998